![]() |
Trials |
Everolimus and temozolmide as first-line treatment in advanced gastrointestinal neuroendocrine carcinoma (G3) with a Ki67 of 20-55%Cancer type: Gastric cancer Phase: II Principal Investigator: Sørbye Halfdan Country: NO Keywords: Norway, Bergen Status: Inclusion completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02248012?term=halfdan+Sorbye&rank=1 |